Pharma major Sun Pharma posted a 5 percent year-on-year (YoY) rise in its consolidated net profit to ₹2,375.5 crore for the July-September quarter against ₹2,262.22 crore in the same period last year.
Meanwhile, its revenue rose over 11 percent YoY to ₹12,192 crore in the quarter under review as compared to ₹10,952.3 crore in the year-ago period.
The firm beat Street estimates on both profit and revenue.
Earnings before interest, taxes, depreciation and amortization (EBITDA), for the quarter, rose nearly 8 percent year-on-year. ₹3,179.30 crore, but operating margin declined by 91 basis points to 26.08 percent.
(This is a developing story)
“Exciting news! WhatsApp Channels are now mint 🚀 Subscribe today by clicking the link and stay up to date with the latest financial insights!” Click here!
Get all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download the Mint News App for Daily Market Updates.
Less
Updated: 01 November 2023, 01:50 PM IST
Denial of responsibility! greenleaselibrary.org is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – at loginhelponline@gmail.com The content will be deleted within 24 hours.
